International Aids Vaccine Initiative
Clinical trials sponsored by International Aids Vaccine Initiative, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- MRNA HIV vaccines enter human trials in south africa Results expected Dec 2026 (estimated)
- Could a gorilla virus help beat HIV? new vaccine trial launches Results expected Mar 2027 (estimated)
- New sudan virus vaccine enters first human tests Results expected Apr 2027 (estimated)
-
Could this new vaccine end tuberculosis?
Vaccine OngoingThis study tests a new vaccine called MTBVAC to see if it can prevent tuberculosis (TB) disease in teens and adults aged 14 to 45 who live in areas where TB is common. About 5,500 volunteers will receive either the vaccine or a placebo, and researchers will track who develops TB …
Phase 2 • Sponsor: International AIDS Vaccine Initiative • Aim: Vaccine
Last updated Sep 11, 2026 00:00 UTC
-
MRNA HIV vaccines enter human trials in south africa
Vaccine OngoingThis early-stage trial tests three experimental mRNA vaccines designed to train the immune system to fight HIV. The study involves 96 healthy adults without HIV in South Africa. Researchers will check for side effects and measure whether the vaccines trigger specific immune cells…
Phase 1 • Sponsor: International AIDS Vaccine Initiative • Aim: Vaccine
Last updated Jul 03, 2026 00:00 UTC